Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Champagne Flows As CTLA-4/PD-1 Pioneers Allison And Honjo Win Nobel Prize

Oct 02 2018

• By Emily Hayes

SC1810_Nobel Award_1094864642_1200.jpg

Related Content

Bristol's CheckMate 067 Revives Debate On Rationing Yervoy/Opdivo Combo

Apr 04 2017

Yervoy Cuts To The Head Of The Line: Ipilimumab Has Unrestricted Label

Mar 28 2011

MD Anderson Helps Pfizer, J&J Play Catch-up In Cancer Immunotherapy

Jan 28 2014

Melanoma Success Paves Way For Path Of Gold In Cancer Immunotherapy

Jun 10 2013

Sanofi/Regeneron's IO Springboard Libtayo Cleared For Skin Cancer

Sep 29 2018

Immuno-Oncology: What To Watch At ASCO 2018

May 18 2018

Roche, Bristol On The Defensive After Merck's Lung Cancer Wins At ASCO

Jun 06 2018

Oncology Disruption Demands Strategic Transformation

Aug 21 2017

Bristol/Medarex: A Transformational Acquisition Rooted In Collaboration

Sep 18 2017

Ipilimumab Data Impress, But Vaccine Control Could Complicate Review

Jun 14 2010

First-Line Chemo Combo Data Help Merck's Keytruda Power Past Opdivo

Jul 30 2018

BIO Notebook Day 1: Other Therapeutic Areas Left Behind As Deal-Making, Financing Focus On Oncology, Rare Diseases

Jun 05 2018

Key Trends In Immuno-Oncology Dealmaking

Apr 21 2016

Related Companies

Bristol Myers Squibb Company

Roche Holding AG

AstraZeneca PLC

Pfizer Inc.

Merck KGaA

Sanofi

Regeneron Pharmaceuticals, Inc.

Jounce Therapeutics, Inc.

Bristol Myers Squibb Company

Ono Pharmaceutical Company, Ltd.

Additional Topics

ImmunoOncology Research & Development Executive Changes BioPharmaceutical

More from R&D

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window